Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.torrentpharma.com | |
Market Cap | 89,224.37 Cr. | |
Enterprise Value(EV) | 93,084.37 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 44.14 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 59.72 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.03 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 211.27 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 12.48 | Calculated using Price: 2,636.30 |
Dividend Yield | 0.83 | Period Ending 2023-03 |
No. of Shares Subscribed | 33.84 Cr. | 338,445,440 Shares |
FaceValue | 5 | |
About Torrent Pharmaceuticals Ltd. | ||
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM. |
1 Day |
|
+1.76% |
1 Week |
|
+4.66% |
1 Month |
|
+3.03% |
3 Month |
|
+4.17% |
6 Month |
|
+39.43% |
1 Year |
|
+63.48% |
2 Year |
|
+92.68% |
5 Year |
|
+191.12% |
10 Year |
|
+862.03% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 34.19 | 57.92 | 23.8 | 15.12 | 9.34 | 21.47 | 23.49 | 13.18 | 20.5 | |
Return on Capital Employed (%) | 26.98 | 45.63 | 20.36 | 13.81 | 9.75 | 15.28 | 17.62 | 14.35 | 20.32 | |
Return on Assets (%) | 11.71 | 20.89 | 10.28 | 5.81 | 3.15 | 7.5 | 9.2 | 5.92 | 9.2 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 2,491 | 3,494 | 4,350 | 4,622 | 4,724 | 4,823 | 5,837 | 5,953 | 6,198 | 6,707 | |
Non Curr. Liab. | 2,505 | 1,995 | 2,303 | 4,142 | 3,861 | 3,299 | 2,924 | 2,238 | 2,823 | 2,563 | |
Curr. Liab. | 2,824 | 3,285 | 2,738 | 5,202 | 5,165 | 5,454 | 4,892 | 4,415 | 5,447 | 4,898 | |
Minority Int. | 0 | 0 | 0 | 1 | |||||||
Equity & Liab. | 7,820 | 8,775 | 9,392 | 13,967 | 13,751 | 13,577 | 13,653 | 12,606 | 14,468 | 14,168 | |
Non Curr. Assets | 3,768 | 4,086 | 4,513 | 8,705 | 8,714 | 8,596 | 8,130 | 7,312 | 9,139 | 8,881 | |
Curr. Assets | 4,051 | 4,680 | 4,879 | 5,262 | 5,038 | 4,979 | 5,522 | 5,165 | 5,314 | 5,287 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 7,820 | 8,775 | 9,392 | 13,967 | 13,751 | 13,577 | 13,653 | 12,606 | 14,468 | 14,168 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 4,653 | 6,667 | 5,816 | 5,950 | 7,673 | 7,939 | 8,005 | 8,508 | 9,620 | 10,474 | |
Other Income | 286 | 229 | 223 | 307 | 64 | 121 | 57 | 197 | 63 | 36 | |
Total Income | 4,939 | 6,896 | 6,039 | 6,257 | 7,736 | 8,061 | 8,061 | 8,705 | 9,683 | 10,510 | |
Total Expenditure | -3,633 | -3,937 | -4,438 | -4,609 | -5,696 | -5,769 | -5,524 | -6,077 | -6,796 | -7,262 | |
PBIDT | 1,306 | 2,959 | 1,601 | 1,648 | 2,040 | 2,292 | 2,537 | 2,628 | 2,887 | 3,248 | |
Interest | -175 | -184 | -206 | -308 | -504 | -451 | -353 | -255 | -333 | -381 | |
Depreciation | -191 | -238 | -307 | -409 | -618 | -654 | -658 | -662 | -707 | -801 | |
Taxation | -189 | -610 | -155 | -253 | -125 | -162 | -274 | -449 | -602 | -660 | |
Exceptional Items | -194 | -357 | -485 | 88 | |||||||
PAT | 751 | 1,733 | 934 | 678 | 436 | 1,025 | 1,252 | 777 | 1,245 | 1,494 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | ||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 751 | 1,733 | 934 | 678 | 436 | 1,025 | 1,252 | 777 | 1,245 | 1,494 | |
Adjusted EPS | 22 | 51 | 28 | 20 | 13 | 30 | 37 | 23 | 37 | 44 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 599 | 810 | 2,742 | 1,009 | 894 | 1,798 | 1,393 | 2,005 | 1,803 | 2,368 | |
Cash Fr. Inv. | -356 | -2,162 | -838 | -787 | -4,707 | -241 | 199 | -449 | -197 | -2,415 | |
Cash Fr. Finan. | 86 | 1,212 | -1,435 | -193 | 3,417 | -1,314 | -1,549 | -1,651 | -1,781 | 77 | |
Net Change | 330 | -140 | 469 | 29 | -395 | 242 | 42 | -95 | -175 | 30 | |
Cash & Cash Eqvt | 955 | 865 | 1,050 | 1,068 | 702 | 940 | 662 | 573 | 398 | 509 |
Tue, 23 Apr 2024
Updates Torrent Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
Fri, 19 Apr 2024
Updates Torrent Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015'. |
Mon, 08 Apr 2024
Updates Torrent Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
Tue, 23 Apr 2024 |
Closing Above Previous High |
Close Within 52 Week High Zone |
Closing Above Previous High for 2 Days |
Making Higher Highs for 2 Days |
High Increase in 6 Months |